A couple weeks ago, we covered Sigma Labs (OTCBB: SGLB), a 3-D printing microcap with big market potential.
Today, we’re going to cover another unique microcap in the 3-D printing space. The company is Sweden-based Arcam AB, and they have their heart set on expansion abroad and in the United States.
Founded in 1997 and trading on the Nasdaq OMX under ticker ARCM.ST since June of last year, Arcam AB is listed as an ADR (American Depositary Receipt) in the U.S. under the ticker AMAVF.
This past Friday, they released their first-half 2013 financial report and it was great news: They reported an 80% increase in sales, and earnings up six times from what was reported in the first half of 2012. This was after converting from the Swedish krona to the USD. Their net profit margins were also up a full 6%.
Another good sign is that insiders and institutions holding the company comprise almost half of the outstanding 4.1 million shares. Their research and development, and intellectual property portfolio is also in top shape for a company that size, with 50 patents secured and 25 patents pending globally. In the U.S., they’ve won nine patents, with 11 patents pending.
Arcam’s technology utilizes what’s called electron beam melting (EMB) and specializes in high-grade metals used in aerospace and orthopedic/medical industries. Here’s how it works: Metal components are built in successive layers from metal powders. These powders are melted by a high-temperature electron beam that fires from electromagnetic coils, and the beam control allows multiple pools to be maintained at the same time. The benefits in this process are speed and accuracy. Plus, the source of the heat is extremely clean, so only the purest metals are produced.
Like Sigma Labs, one of Arcam’s big customers is Boeing. They also have ties to Airbus and NASA.
One important factor in any aerospace craft is a low “buy-to-fly ratio.” Obviously, when you’re designing an aircraft for speed and resilience, you want it built out of a material that’s as light and strong as possible. Arcam’s 3-D printers can meet such needs for commercial and military aircraft, space applications, missiles and engine components for the aerospace industry.
Then there are the medical and orthopedic industry products. As you know, the baby boomers are retiring in the thousands every day, and there is a graying of America happening right now. This is one reason why the national budget will count health care as its greatest fiscal obligation. Therefore, there’s tremendous demand for orthopedic implants. Arcam is well positioned to provide both standard and custom implants for a lower cost at higher quality than what’s currently on the market.
Already, their products have received FDA approval for use in the U.S. Championing this cause is the Arcam Q10, a product that’s expected to make major headway in the coming years. They’ve already secured customers by entering in strategic alliances with California-based Renovis Surgical Technologies and Connecticut-based DiSanto Technology Inc., a full-service medical device contract manufacturer.
The company will showcase their products in New Orleans in fall 2013 at the North American Spine Society Annual Meeting, hoping to inch their way further into mainstream awareness. On top of that, their sales are outstanding. They’ve delivered 11 of their 3-D printing systems in the first half of the year and have received orders for 12 more in the second half of 2013.
All in all, this looks like a solid company. Most of the 3-D printing companies that are all the rage right now have overlooked the smaller microcaps, especially the ones outside the U.S. Arcam AB is outside the mainstream, though it shouldn’t be long before everyone knows it by name — and a few risk-takers benefit from its entrepreneurial success.
Josh Grasmickfor Tomorrow in Review
The ability of any company to generate meaningful organic revenue growth and positive earnings is largely dependent on new product offerings that effectively address a need or limitation experienced by their customers.
Josh Grasmick is managing editor of Tomorrow in Review and associate editor of Technology Profits Confidential and Breakthrough Technology Alert. After graduating from Washington College with a degree in English, the self-described autodidact was interviewed by Time magazine for his novel entrepreneurship and worldwide eco-adventures. His experience with those in the fields of science, medicine and technology puts readers ahead of the curve and on top of the market.
They are at their 52 week high at $435.00 . They were low 52 weeks ago at $69.00. A little late to the dance are we?
ARCM stock marketcap at 480 swedish Krone is roughly $300 mln.
This is not even half the marketcap of XONE.
1/14th the cap of 3D systems. (4.4 Bln)
There are only 4.1 mln shares in the float (june-28-2013)
Lot of upward potential!
When it comes to central bankers and the global economy, you might say the inmates are running the asylum. Today, Addison Wiggin sits down with Jim Rickards to discuss the ever-changing world of finance, the likelihood of hyperinflation hitting the U.S., and the massive economic experiment being conducted by the world's central bankers. Read on...
ISIS is a radical terrorist organization wreaking havoc across Northern Iraq. But its members come from all over the world - including many from Western Countries. The question no one's asking is why... Why are foreigners flocking to the Middle East to fight alongside ISIS? And how far does Obama really want to go? Chris Campbell explores...
When it comes to the stock market, October gets a bad rap. It's true, there have been some major crashes in October (ahem... Black Monday, Black Tuesday, etc.) but on a shorter timeline this month hasn't been nearly as bad as you might think. Today, Greg Guenthner offers an optimistic look at the month investors love to hate. Read on...
Big government doesn't come cheap. And right now the U.S. government is one of the biggest in history. So far the budget writers have been able to move money around to keep the machine moving. But as Byron King points out, that will soon become much more difficult. Read on for the full story...
In the late '90s, financial TV personalities like Jim Cramer became mega stars - often drawing more ratings the ESPN. But that was over 15 years ago... That couldn't happen again, could it? Today, Wayne Mulligan details the new flock of personalities that are set to cash-in on a different kind of investment boom. Read on...